J&J launches energy generator compatible with Ottava robot
Johnson & Johnson said the Dualto energy system’s design allows for up to 46% less footprint than separate generators.
J&J launches energy generator compatible with Ottava robot Read More »
Johnson & Johnson said the Dualto energy system’s design allows for up to 46% less footprint than separate generators.
J&J launches energy generator compatible with Ottava robot Read More »
Many HHS department heads and employees were unaware of plans to fire some 10,000 employees until they were publicly announced Thursday, sources said.
‘Everything is word of mouth’: HHS employees face uncertainty in looming Trump layoffs Read More »
Many HHS department heads and employees were unaware of plans to fire some 10,000 employees until they were publicly announced Thursday, sources said.
‘Everything is word of mouth’: HHS employees face uncertainty in looming Trump layoffs Read More »
With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems already on the market.
Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former Masimo exec Jon Coleman joined Dexcom, and Sibionics’ CGM earned the CE mark.
Newly public Beta Bionics reports sales surge; Dexcom hires CCO Read More »
Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular tachycardia when the FDA issued a Complete Response Letter on Friday.
Milestone Stock Crashes After Surprise Tachycardia Drug Rejection Read More »
Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen on Thursday, but the company hopes to win patients over.
In a letter to Senate Majority Leader John Thune, hundreds of groups said the potential cuts would “shred our nation’s social safety net,” delaying access to care and ultimately drive up healthcare costs.
Advocacy groups say Medicaid cuts would be ‘catastrophic’ Read More »
The European Union’s CHMP said that the benefits of the drug, already approved in the U.S., do not outweigh the risk of potentially fatal brain swelling and bleeding.
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi Read More »
Fuente Automatización y Tecnología: 7 Tendencias Claves en la Transformación Digital Lograr concebir una transformación digital significativa es una apuesta que debe conquistar tu empresa si, además de posicionarla como líder en el mercad …